SE386174B - Forfarande for framstellning av bensoxazolderivat. - Google Patents

Forfarande for framstellning av bensoxazolderivat.

Info

Publication number
SE386174B
SE386174B SE7307005A SE7307005A SE386174B SE 386174 B SE386174 B SE 386174B SE 7307005 A SE7307005 A SE 7307005A SE 7307005 A SE7307005 A SE 7307005A SE 386174 B SE386174 B SE 386174B
Authority
SE
Sweden
Prior art keywords
procedure
preparation
benzoxazole derivatives
derivatives
benzoxazole
Prior art date
Application number
SE7307005A
Other languages
English (en)
Swedish (sv)
Inventor
D Evans
D W Dunwell
T A Hicks
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of SE386174B publication Critical patent/SE386174B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
SE7307005A 1972-05-18 1973-05-17 Forfarande for framstellning av bensoxazolderivat. SE386174B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2340972A GB1435721A (en) 1972-05-18 1972-05-18 Benzoxazole derivatives

Publications (1)

Publication Number Publication Date
SE386174B true SE386174B (sv) 1976-08-02

Family

ID=10195157

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7307005A SE386174B (sv) 1972-05-18 1973-05-17 Forfarande for framstellning av bensoxazolderivat.
SE7509387A SE434399B (sv) 1972-05-18 1975-08-22 Forfarande for framstellning av benoxazolderivat
SE7710602A SE435838B (sv) 1972-05-18 1977-09-21 Bensoxazolderivat sasom mellanprodukt

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE7509387A SE434399B (sv) 1972-05-18 1975-08-22 Forfarande for framstellning av benoxazolderivat
SE7710602A SE435838B (sv) 1972-05-18 1977-09-21 Bensoxazolderivat sasom mellanprodukt

Country Status (31)

Country Link
US (1) US3912748A (da)
JP (6) JPS5912672B2 (da)
KR (1) KR780000234B1 (da)
AR (4) AR230991A1 (da)
AT (1) AT333752B (da)
BE (1) BE799790A (da)
BG (1) BG21408A3 (da)
CA (1) CA1029019A (da)
CH (5) CH594643A5 (da)
CS (1) CS200455B2 (da)
CY (1) CY1016A (da)
DD (1) DD105229A5 (da)
DE (1) DE2324443A1 (da)
DK (1) DK140340B (da)
ES (1) ES414863A1 (da)
FR (2) FR2184966B1 (da)
GB (1) GB1435721A (da)
HK (1) HK72579A (da)
HU (1) HU167933B (da)
IE (2) IE37564B1 (da)
IL (2) IL42102A (da)
KE (1) KE2975A (da)
MY (1) MY8000063A (da)
NL (1) NL170145C (da)
PH (3) PH9685A (da)
PL (3) PL94208B1 (da)
RO (2) RO66800A (da)
SE (3) SE386174B (da)
SU (3) SU574157A3 (da)
YU (3) YU130473A (da)
ZA (1) ZA732791B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888864A (en) 1973-06-29 1975-06-10 Hoffmann La Roche Amino lower alkyl ether derivatives of opium alkaloids
GB1495488A (en) * 1976-06-23 1977-12-21 Ippco Int Pharma Patents Co Es Optically active 2-(2-phenyl-5-benzoxazolyl)propionic acids
US4087437A (en) * 1976-09-07 1978-05-02 Eli Lilly And Company 2-Phenyl-5-benzoxazolylalkanoic acid purification process
GB1590587A (en) * 1977-06-28 1981-06-03 Lilly Industries Ltd Benoxaprofen
IT1099589B (it) * 1978-08-04 1985-09-18 Ravizza Spa Processo per la preparazione di derivati dell'acido benzoxazolil propionico
CA1125768A (en) * 1978-10-31 1982-06-15 Hoffmann-La Roche Limited Benzoxazole derivatives
GB2058381B (en) 1979-07-18 1983-01-19 Fuji Photo Film Co Ltd Colour photographic light-sensitive material containing dye-releasing redox compound
GR75153B (da) * 1981-03-27 1984-07-13 Lilly Co Eli
IT1157295B (it) * 1982-07-19 1987-02-11 Ravizza Spa Processo perfezionato per la preparazione di derivati dell'acido benzoxazolil propionico
DE3413875A1 (de) * 1984-04-12 1985-10-17 Ludwig Heumann & Co GmbH, 8500 Nürnberg Benzothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel
IT1177017B (it) * 1984-10-22 1987-08-26 Ravizza Spa Processo per la preparazione dell'acido 2(4-flurofenil)alfa-metil-5-benzox azoloacetico
US4873259A (en) * 1987-06-10 1989-10-10 Abbott Laboratories Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds
US4822809A (en) * 1987-11-13 1989-04-18 Abbott Laboratories Benzazole lipoxygenase inhibiting compounds
IT1233836B (it) * 1988-01-13 1992-04-21 Euroresearch Srl Sali idrosolubili dell'acido (+)2-(4 fluorofenil)-alfa-metil-5 benzoxazolo acetato.
UA83620C2 (ru) * 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
AU2003283597A1 (en) * 2002-11-16 2004-06-15 Oxford Glycosciences (Uk) Ltd Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors
US7652036B2 (en) * 2003-02-25 2010-01-26 Topotarget Uk Limited Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors
DK1856031T3 (da) * 2004-12-15 2009-06-29 Dompe Pha R Ma Spa Res & Mfg 2-arylpropionsyrederivater og farmaceutiske sammensætninger indeholdende disse
ES2393768T3 (es) 2005-05-26 2012-12-27 Neuron Systems, Inc Derivado de quinolina para el tratamiento de enfermedades retinianas
JP5369854B2 (ja) 2008-04-21 2013-12-18 住友化学株式会社 有害節足動物防除組成物および縮合複素環化合物
KR102435676B1 (ko) 2013-01-23 2022-08-24 알데이라 테라퓨틱스, 아이엔씨. 독성 알데히드 관련된 질병 및 치료
KR20150120380A (ko) 2013-01-25 2015-10-27 알데이라 테라퓨틱스, 아이엔씨. 황반 변성의 치료에서 신규한 트랩
WO2016021706A1 (ja) * 2014-08-08 2016-02-11 カズマパートナーズ株式会社 縮合複素環化合物
JP6947406B2 (ja) 2015-08-21 2021-10-13 アルデイラ セラピューティクス， インコーポレイテッド 重水素化化合物およびその使用
CN109152774A (zh) 2016-05-09 2019-01-04 奥尔德拉医疗公司 眼部炎性病症和疾病的组合治疗
US10414732B2 (en) 2017-03-16 2019-09-17 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
EP3694500A4 (en) 2017-10-10 2021-06-30 Aldeyra Therapeutics, Inc. TREATMENT OF INFLAMMATORY DISORDERS
US20220017475A1 (en) 2018-08-06 2022-01-20 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
CA3113462A1 (en) 2018-09-25 2020-04-02 Aldeyra Therapeutics, Inc. Formulations for treatment of dry eye disease
US11786518B2 (en) 2019-03-26 2023-10-17 Aldeyra Therapeutics, Inc. Ophthalmic formulations and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD70860A (da) *
NL285932A (da) * 1961-11-27
CH516339A (de) * 1969-03-03 1971-12-15 Ciba Geigy Ag Verwendung von Azolverbindungen als Antioxydantien
DE2118315C3 (de) * 1970-04-20 1975-04-03 Sumitomo Chemical Co., Ltd., Osaka (Japan) 2-(1H)-Chinazolinonderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
IL37633A (en) * 1970-09-10 1975-08-31 Merck & Co Inc 2-(4-(2-benzoxazolyl)phenyl)alkanoic acid derivatives
DE2115926C3 (de) * 1971-04-01 1978-05-03 C.H. Boehringer Sohn, 6507 Ingelheim 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel
GB1491863A (en) * 1973-10-23 1977-11-16 Lilly Industries Ltd 2,5-or 2,6-disubstituted benzoxazoles
GB1590587A (en) * 1977-06-28 1981-06-03 Lilly Industries Ltd Benoxaprofen

Also Published As

Publication number Publication date
AR230991A1 (es) 1984-08-31
HU167933B (da) 1976-01-28
AR212010A1 (es) 1978-04-28
CH594643A5 (da) 1978-01-13
YU36298B (en) 1982-06-18
SE7710602L (sv) 1977-09-21
JPS6021976B2 (ja) 1985-05-30
US3912748A (en) 1975-10-14
AU5590773A (en) 1974-11-21
IL48711A0 (en) 1976-02-29
IE37564L (en) 1973-11-18
NL170145B (nl) 1982-05-03
HK72579A (en) 1979-10-19
ATA432573A (de) 1976-04-15
KE2975A (en) 1979-07-20
JPS56167673A (en) 1981-12-23
AR207857A1 (es) 1976-11-08
CS200455B2 (en) 1980-09-15
YU117079A (en) 1981-08-31
SU580837A3 (ru) 1977-11-15
FR2184966A1 (da) 1973-12-28
MY8000063A (en) 1980-12-31
PH11718A (en) 1978-05-30
IL42102A0 (en) 1973-06-29
GB1435721A (en) 1976-05-12
AT333752B (de) 1976-12-10
SU582762A3 (ru) 1977-11-30
SE7509387L (sv) 1975-08-22
FR2184966B1 (da) 1979-01-12
PH9685A (en) 1976-02-10
PH10704A (en) 1977-08-24
JPS56167674A (en) 1981-12-23
IE37563B1 (en) 1977-08-17
CH587834A5 (da) 1977-05-13
JPS4954363A (da) 1974-05-27
DK140340B (da) 1979-08-06
SE435838B (sv) 1984-10-22
JPS56167675A (en) 1981-12-23
RO66800A (ro) 1982-03-24
IL42102A (en) 1977-07-31
PL89247B1 (da) 1976-11-30
CH595361A5 (da) 1978-02-15
RO66278A (ro) 1981-06-26
JPS59161346A (ja) 1984-09-12
CH592071A5 (da) 1977-10-14
SU574157A3 (ru) 1977-09-25
FR2284592A1 (fr) 1976-04-09
JPS56167645A (en) 1981-12-23
IE37563L (en) 1973-11-18
YU130473A (en) 1981-08-31
BG21408A3 (da) 1976-05-20
PL94208B1 (da) 1977-07-30
ZA732791B (en) 1974-12-24
FR2284592B1 (da) 1979-01-05
BE799790A (fr) 1973-11-19
SE434399B (sv) 1984-07-23
ES414863A1 (es) 1976-02-01
DE2324443A1 (de) 1973-11-29
IE37564B1 (en) 1977-08-17
NL170145C (nl) 1982-10-01
CA1029019A (en) 1978-04-04
YU117179A (en) 1981-08-31
JPS5929185B2 (ja) 1984-07-18
CH595362A5 (da) 1978-02-15
PL92565B1 (da) 1977-04-30
JPS5912672B2 (ja) 1984-03-24
NL7307018A (da) 1973-11-20
DD105229A5 (da) 1974-04-12
KR780000234B1 (en) 1978-07-01
CY1016A (en) 1979-11-23
AR205021A1 (es) 1976-03-31
DK140340C (da) 1979-12-31

Similar Documents

Publication Publication Date Title
SE386174B (sv) Forfarande for framstellning av bensoxazolderivat.
SE416298B (sv) Forfarande for framstellning av nya bensimidazolinon derivat
OA04406A (fr) Procédé de préparation de dérivés de 14-hydroxy-morphinane.
OA04368A (fr) Procédé de préparation de nouveaux acylamino acides.
SE427276B (sv) Forfarande for framstellning av d-homosteroider
SE7406973L (sv) Forfarande for framstellning av nya pleiaden-derivat
FR905976A (fr) Procédé de fabrication d'acides acylmercaptocarboxyliques et de dérivés fonctionnels de ces acides
FR1247320A (fr) Procédé de préparation des dérivés de l'aldéhyde de la vitamine a
DK140255B (da) Analogifremgangsmåde til fremstilling af benzoxazolderivater.
CH535197A (fr) Procédé de préparation des acides hydroxy-2(hydroxy-3 alcényl)-5 cyclopentylalconoïques et utilisation d'esters de ces acides
FR890796A (fr) Procédé de préparation d'acides ascorbiques
FR897785A (fr) Acides 4. 4'-dihalogène-benzophénone-3. 3'-disulfoniques et procédé de préparation de ces acides